首页> 外文期刊>Photodermatology, photoimmunology and photomedicine >Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis.
【24h】

Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis.

机译:临床规模生成的强表达CD83的树突状细胞使用体外光采。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Many strategies are currently being pursued in order to generate mature dendritic cells (DC) to be used for immunotherapy. A potent anti-tumour influence by extracorporeal photopheresis has been documented for cutaneous T-cell lymphoma, and a major mechanism of action has been suggested to be generation of DC presenting tumour antigens. Purpose: To determine the potential of a simple clinical photopheresis protocol for large-scale development of mature DC. Methods: A standard monocyte-enriched leukapheresis preparation of 10(9)-10(10) cells was derived during each of five consecutive treatment sessions of a patient with cutaneous T-cell lymphoma. The cells were incubated overnight in autologous plasma with no addition of growth medium. Cell surface lymphocyte, monocyte and DC markers were determined using multi-colour flow cytometry. Results: We find signs of activation of the CD14+ monocytes, as well as the appearance of a minor population of mature DC negative for CD14 but with strong CD83 expression. Conclusions: With a procedure appropriate for routine clinical use, a total number of 10(6)-10(7) DC ready for patient reinfusion can be prepared within 24 h. Our findings indicate the need to further explore the capacity of photopheresis to stimulate cancer patients' anti-tumour defence reaction.
机译:背景:目前正在采取许多策略以产生成熟的树突状细胞(DC)以用于免疫治疗。对于皮肤T细胞淋巴瘤,已经证明了通过体外光胆疗法的有效抗肿瘤作用,并且已经表明主要的作用机理是产生DC呈递肿瘤抗原。目的:确定简单的临床光采方案对于成熟DC大规模开发的潜力。方法:在患有皮肤T细胞淋巴瘤的患者的连续五次治疗过程中,分别获得了富含标准单核细胞的10(9)-10(10)细胞的白细胞分离术制剂。将细胞在不添加生长培养基的自体血浆中孵育过夜。使用多色流式细胞仪确定细胞表面的淋巴细胞,单核细胞和DC标记。结果:我们发现了CD14 +单核细胞活化的迹象,以及少数CD14阴性但具有强CD83表达的成熟DC的外观。结论:通过适合常规临床使用的程序,可以在24小时内准备好总数为10(6)-10(7)DC的患者再输注液。我们的发现表明有必要进一步探索光透疗法刺激癌症患者抗肿瘤防御反应的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号